New York State Common Retirement Fund’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
153,053
+100,983
+194% +$2.41M ﹤0.01% 1158
2025
Q4
$1.39M Sell
52,070
-3,804
-7% -$90.9K ﹤0.01% 1562
2025
Q3
$1.19M Buy
55,874
+4,500
+9% +$106K ﹤0.01% 1618
2025
Q2
$1.11M Hold
51,374
﹤0.01% 1624
2025
Q1
$853K Hold
51,374
﹤0.01% 1697
2024
Q4
$943K Buy
51,374
+6,310
+14% +$102K ﹤0.01% 1698
2024
Q3
$693K Sell
45,064
-12,600
-22% -$210K ﹤0.01% 1816
2024
Q2
$937K Sell
57,664
-155,259
-73% -$2.51M ﹤0.01% 1789
2024
Q1
$3.94M Sell
212,923
-716
-0.3% -$17.7K 0.01% 1208
2023
Q4
$6.69M Sell
213,639
-19,870
-9% -$475K 0.01% 1011
2023
Q3
$4.87M Buy
233,509
+71,141
+44% +$1.93M 0.01% 1120
2023
Q2
$3.89M Buy
162,368
+99,237
+157% +$2.21M 0.01% 1266
2023
Q1
$1.19M Sell
63,131
-22,604
-26% -$430K ﹤0.01% 1788
2022
Q4
$1.36M Sell
85,735
-44
-0.1% -$688 ﹤0.01% 1826
2022
Q3
$1.4M Buy
85,779
+6,546
+8% +$106K ﹤0.01% 1794
2022
Q2
$1.12M Sell
79,233
-7,054
-8% -$132K ﹤0.01% 1953
2022
Q1
$2.09M Buy
86,287
+77
+0.1% +$1.86K ﹤0.01% 1719
2021
Q4
$2.01M Sell
86,210
-222
-0.3% -$4.46K ﹤0.01% 1767
2021
Q3
$1.44M Sell
86,432
-15,268
-15% -$294K ﹤0.01% 1941
2021
Q2
$2.48M Sell
101,700
-19,600
-16% -$442K ﹤0.01% 1739
2021
Q1
$3.13M Sell
121,300
-22,000
-15% -$968K ﹤0.01% 1521
2020
Q4
$7.66M Sell
143,300
-16,600
-10% -$824K 0.01% 1078
2020
Q3
$6.6M Sell
159,900
-20,730
-11% -$895K 0.01% 1051
2020
Q2
$8.76M Buy
180,630
+69,765
+63% +$3.35M 0.01% 930
2020
Q1
$4.68M Sell
110,865
-11,915
-10% -$491K 0.01% 1081
2019
Q4
$5.25M Sell
122,780
-4,470
-4% -$194K 0.01% 1229
2019
Q3
$4.58M Buy
127,250
+19,350
+18% +$587K 0.01% 1272
2019
Q2
$2.88M Sell
107,900
-9,570
-8% -$244K ﹤0.01% 1474
2019
Q1
$3.15M Buy
117,470
+18,070
+18% +$422K ﹤0.01% 1414
2018
Q4
$1.61M Sell
99,400
-10,100
-9% -$196K ﹤0.01% 1664
2018
Q3
$2.27M Hold
109,500
﹤0.01% 1614
2018
Q2
$1.67M Sell
109,500
-101,800
-48% -$1.82M ﹤0.01% 1798
2018
Q1
$4.75M Buy
211,300
+3,500
+2% +$96.9K 0.01% 1250
2017
Q4
$6.26M Sell
207,800
-7,000
-3% -$224K 0.01% 1164
2017
Q3
$8.09M Buy
214,800
+6,500
+3% +$211K 0.01% 1038
2017
Q2
$5.81M Sell
208,300
-1
-0% -$30 0.01% 1203
2017
Q1
$7.16M Buy
208,301
+8,501
+4% +$300K 0.01% 1094
2016
Q4
$5.76M Buy
199,800
+2,331
+1% +$61.7K 0.01% 1183
2016
Q3
$6.28M Buy
197,469
+4,290
+2% +$145K 0.01% 1126
2016
Q2
$6.27M Buy
193,179
+87,294
+82% +$2.92M 0.01% 1149
2016
Q1
$2.96M Buy
105,885
+10,865
+11% +$237K ﹤0.01% 1428
2015
Q4
$3.39M Buy
95,020
+11,400
+14% +$402K 0.01% 1389
2015
Q3
$2.77M Sell
83,620
-36,542
-30% -$1.52M ﹤0.01% 1455
2015
Q2
$5.03M Buy
120,162
+92,269
+331% +$3.57M 0.01% 1353
2015
Q1
$909K Sell
27,893
-6,167
-18% -$212K ﹤0.01% 1900
2014
Q4
$1.08M Buy
+34,060
New +$966K ﹤0.01% 1809

Other funds holding ACAD